Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07199907 · ClinicalTrials.gov registry record · NA

Hippocampal and Frontoparietal Development and Inference

A NA study of Healthy, sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
142
Enrollment target
1
Study location

NCT07199907: Recruiting NA study of Healthy, sponsored by University of Texas at Austin.

NCT07199907 is a NA study of Healthy that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 142 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07199907, a NA study of Healthy, is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
142 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to test if an intervention used to manipulate memory and inference can improve our understanding of how brain development supports these abilities in healthy adolescent and adult volunteers. The main questions it aims to answer are: (1) Do hippocampus and ventromedial prefrontal cortex shift from forming simple memories for singular experiences to more complex memories that link numerous experiences together?; (2) Does an improved ability to retrieve prior memories in parietal cortex during new learning have consequences for how those memories are organized at different ages?; and (3) Does the emerging memory control supported by ventromedial prefrontal cortex development facilitate the formation of optimally-organized memory representations? Adolescent participants (13-18 years) will perform two experimental tasks during functional magnetic resonance imaging (fMRI) scanning at three timepoints (T1-T3), spaced 1.5 years apart. Researchers will compare behavioral and neuroimaging data to a separate group of adults (19-25 years) who will perform the task at a single timepoint (T1). The tasks and comparison groups will allow us to isolate the neural processes that support memory and inference behavior, and how these processes change with age.

Primary Outcome

Within the adolescent group, changes in BOLD signal during task performance, as measured by functional magnetic resonance imaging (fMRI), will be assessed across three separate timepoints.

Conditions Studied

Interventions

  • BEHAVIORAL Associative Inference
  • BEHAVIORAL Probabilistic Inference

Study Locations (1)

Texas

  • The University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 142 participants
Start Date 2025-02-20
Est. Completion 2029-08
Phase NA
University of Texas at Austin

257 total trials

What NCT07199907 shows while recruiting

NCT07199907 is an interventional study that assigns participants to a tested intervention. The registered 142 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (78% lower).

The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Associative Inference is the first listed.

NCT07199907 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT07199907 about?

NCT07199907 is a clinical study titled "Hippocampal and Frontoparietal Development and Inference". The goal of this clinical trial is to test if an intervention used to manipulate memory and inference can improve our understanding of how brain development supports these abilities in healthy adolescent and adult volunteers. The main questions it aims to answer are: (1) Do hippocampus and ventromed...

What is the current status of trial NCT07199907?

This trial is currently recruiting. It is a NA study. The enrollment target is 142 participants. The study started on 2025-02-20. Estimated completion is 2029-08.

What conditions does trial NCT07199907 study?

This clinical trial studies the following conditions: Healthy.

What interventions are being tested in trial NCT07199907?

The interventions under investigation include: Associative Inference (BEHAVIORAL), Probabilistic Inference (BEHAVIORAL).

Who is sponsoring clinical trial NCT07199907?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07199907 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Healthy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07199907's enrollment target sits among peer trials

142 163rd of 1090 higher than 928 of 1,090 other Healthy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03933631 · 142 participants · Phase 3

    Pilocarpine Use After Kahook Goniotomy

  • NCT04938349 · 142 participants · NA

    Dual Task Perturbation Training for OAwMCI

  • NCT06117254 · 142 participants · NA

    Hearing Aids for Veterans With Functional Hearing Difficulties

  • NCT06463665 · 142 participants · Phase 2

    Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07199907, the US trial registry maintained by the National Library of Medicine. NCT07199907 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.